For The Better

Growth stocks like Blink Charging had a hot streak last month.

A debt move isn’t being cheered by investors today.

China’s biggest video game watching services aren’t going to be allowed to become a monopoly after all.

The IPO enthusiasm is beginning to wane.

Reuters says it’s going private. But Weibo says it isn’t.

Brazil continues to struggle to get the pandemic under control.

The company’s latest letter from the FDA wasn’t what investors had hoped for.

The market showed signs of weakness coming out of the holiday weekend.

The company’s shares got caught up in the uncertainty caused by a government crackdown on U.S.-listed Chinese companies.

Here are two potential reasons for the decline in the electric-car maker’s stock price today.

There’s a lot of collateral damage being caused by the downdraft.

A look at auto news.

This semiconductor chip designer is just scratching the surface of multibillion-dollar opportunities.

The CBD company’s shares bounced back after an early 10% drop today.

The company announced preliminary revenue per available room estimates for the second quarter of 2021, and a 1-for-10 reverse stock split.

Increasing its share count by 5% didn’t seem like such a big deal, but it’s off the table in a move to please its retail investors instead of its balance sheet.

Want to max out the size of your Social Security checks? You’re going to have to earn a lot of money.

New data from Israel appears to be weighing on both vaccine stocks.

Generally speaking, biotech is a pretty innovative industry — with a few notable bad apples.

With its stock surging, the creative content platform operator needs to post strong second-quarter earnings to keep its stock moving upward.